ALPMF (Astellas Pharma) FCF Yield % : 4.45 (As of Dec. 12, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Astellas Pharma FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Astellas Pharma's Trailing 12-Month Free Cash Flow is $831 Mil, and Market Cap is $18,558 Mil. Therefore, Astellas Pharma's FCF Yield % for today is 4.45%.

The historical rank and industry rank for Astellas Pharma's FCF Yield % or its related term are showing as below:

ALPMF' s FCF Yield % Range Over the Past 10 Years
Min: 1.79 Med: 5.54 Max: 9.8
Current: 4.45

During the past 13 years, the highest FCF Yield % of Astellas Pharma was 9.80%. The lowest was 1.79%. And the median was 5.54%.

ALPMF's FCF Yield % is ranked better than
76.52% of 1039 companies
in the Drug Manufacturers industry
Industry Median: 0.13 vs ALPMF: 4.45

Astellas Pharma's FCF Margin % for the quarter that ended in Sep. 2024 was 10.41%.

Astellas Pharma FCF Yield % Historical Data

The historical data trend for Astellas Pharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma FCF Yield % Chart

Astellas Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Yield %

Get a 7-Day Free Trial

4.52

7.35

5.39

6.98

3.00

Astellas Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial															1.09	4.14	6.94	-1.79	6.72

Competitive Comparison of Astellas Pharma's FCF Yield %

For the Drug Manufacturers - General subindustry, Astellas Pharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Astellas Pharma's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Astellas Pharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Astellas Pharma's FCF Yield % falls into.

Astellas Pharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Astellas Pharma's FCF Yield % for the fiscal year that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	600.58	/	20019.9615
	=	3.00%

Astellas Pharma's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	336.934	*	4	/	20046.432
	=	6.72%

Astellas Pharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Astellas Pharma FCF Yield % Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (OTCPK:ALPMF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ALPMY:USA 4503:Japan YPH:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a specialty global pharmaceutical company. The company focuses on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. The company operates its business in approximately 70 countries around the world. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.